4[4]Garces K.Drug eluting stents:managing coronary artery stenosis following PTCA[J].Issues Emerg Health Technol,2002,40:1-6.
5[5]Radke PW,Blindt R,Haager PK,et al.Rotational atherectomy for the treatment of in-stent restenosis[J].Minerva Cardioangiol,2002,50:555-563.
6[6]Khurana R,Martin JF,Zachary I.Gene therapy for cardiovascular disease:a case for cautious optimism[J].Hypertension,2001,38:1210-1216.
7[7]Fang S,Sharma RV,Bhalla RC.Enhanced recovery of injury-caused downregulation of Paxillin protein by eNOS gene expression in rat carotid artery mechanism of NO inhibition of intimal hyperplasia?[J].Arterioscler Thromb Vasc Biol,1999,19:147-152.
8[8]Hedman M,Hartikainen J,Syvanne M,et al.Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia:phase Ⅱ results of the kuopio angiogenesis trial(KAT)[J].Circulation,2003,107:2677-2683.
9[9]Emanueli C,Salis MB,Chao J,et al.Adenovirus-mediated human tissue kallikrein gene delivery inhibits neointima formation induced by interruption of blood flow in mice[J].Arterioscler Thromb Vasc Biol,2000,20:1459-1466.
10[10]Scherrer-Crosbie M,Ullrich R,Bloch KD,et al.Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice[J].Circulation,2001,104:1286-1291.
